Today marks the release of the MinKNOW App for iOS and Android devices, now available to download from the Apple Store and Google Play. MinKNOW is the operating software that drives nanopore sequen...

Somatic mutations are the driving force behind cancer development, and structural variations (SVs) are more and more being recognised as an important class of these mutations. The detection of SVs i...

Adam Ewing leads the Translational Bioinformatics Group at the Mater Research Institute - University of Queensland in Australia, where he works to develop methods and software for analysing high t...

The significance of structural variation in human genomics is becoming increasingly established in many fields, from cancer to neurology and the mechanisms of rare disease. With research moving at a...

This week we heard from Ariel Gershman, Shruti Iyer and Tuuli Lappalainen on their latest research addressing some of the key challenges in human genomics using nanopore technology. The talks are no...

- announced at the 2020 American Society of Human Genetics (ASHG) Meeting. Oxford, UK, 28th October 2020. Oxford Nanopore announces multiple releases that expand and improve its sequencing techno...

ASHG 2020 has moved online this year but there’s still plenty going on and lots of ways you can find out about how human genomics researchers are overcoming some of the big challenges in the field...

In this blog, Tao Jiang describes his work on the development of the structural variant (SV) caller cuteSV. Read on to find out how the cuteSV bioinformatics pipeline works, how it performs relative...

Oxford, UK: Oxford Nanopore Technologies has raised £84.4M in new capital. The funding comes from existing investors and new investors, including International Holdings Company (IHC), RPMI Railpen...

Oxford Nanopore, the Bill & Melinda Gates Foundation, US CDC, Microsoft and Illumina collaborate with the Africa Centres for Disease Control and Prevention (Africa CDC) to launch Africa Pathogen...

LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a palm-sized de...

Accurate molecular diagnosis of cancer-causing germline variants enables increased screening, early detection, prevention, and optimal treatment, if cancer does arise in predisposed patients and t...

Guy has extensive experience in healthcare and technology investment and entrepreneurship. He was previously on the leadership team at Harel Insurance Investments and Financial Services, the largest...

In this blog, Filippo Martignano shares his research into copy number variation (CNV) analysis in cancer, from cell-free DNA samples, using shallow whole-genome sequencing. Read on to hear why he ch...

Scientists from the University of Oxford’s Nuffield Department of Medicine, Public Health England Porton Down (PHE), the University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust ha...

New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequencing with...

In this blog, Alba Sanchis-Juan, Javier Corral, and Belén de la Morena-Barrio describe their research into the genetic basis of thrombophilia, and how nanopore long sequencing reads were needed to r...

In this blog, Katherine Dixon shares her team’s work on identifying structural variants in cancer genomes, and she explains why identifying them accurately is so important. Katherine DixonI am a...

Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with the potenti...

The first telomere-to-telomere human chromosome was published in Nature this week — a landmark achievement for genomics researchers. Lead author Karen Miga, from the UC Santa Cruz Genomics Institut...

Daniela Soto is a Ph.D. candidate in the Integrative Genetics and Genomics program at UC Davis, working in the Dennis Lab where she is using long-read sequencing technologies to unveil the variabi...

LamPORE is a new assay, in advanced development at Oxford Nanopore. It is designed to detect the presence of SARS-CoV-2, the virus that causes COVID-19, in a saliva, swab or environmental samples. ...

Company launches Q Line sequencing portfolio for users in regulated settings Oxford Nanopore today announced its pathway towards providing products for the diagnostics and other regulated markets....

London Calling this year took a very different format, going online for the first time ever. With over 5,500 people tuning in to see the action, either live or on-demand, it was a fantastic two-and-...